Literature DB >> 20579680

Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.

Melissa Lazar1, Jennifer Sullivan, Galina Chipitsyna, Tamer Aziz, Ahmed F Salem, Qiaoke Gong, Agnes Witkiewicz, David T Denhardt, Charles J Yeo, Hwyda A Arafat.   

Abstract

BACKGROUND: Cigarette smoke and nicotine are among the leading environmental risk factors for developing pancreatic ductal adenocarcinoma (PDA). We showed recently that nicotine induces osteopontin (OPN), a protein that plays critical roles in inflammation and tumor metastasis. We identified an OPN isoform, OPNc, that is selectively inducible by nicotine and highly expressed in PDA tissue from smokers. In this study, we explored the potential proinflammatory role of nicotine in PDA through studying its effect on the expression of monocyte chemoattractant protein (MCP)-1 and evaluated the role of OPN in mediating these effects.
METHODS: MCP-1 mRNA and protein in PDA cells treated with or without nicotine (3-300 nmol/L) or OPN (0.15-15 nmol/L) were analyzed by real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Luciferase-labeled promoter studies evaluated the effects of nicotine and OPN on MCP-1 transcription. Intracellular and tissue colocalization of OPN and MCP-1 were examined by immunofluorescence and immunohistochemistry.
RESULTS: Nicotine treatment significantly increased MCP-1 expression in PDA cells. Interestingly, blocking OPN with siRNA or OPN antibody abolished these effects. Transient transfection of the OPNc gene in PDA cells or their treatment with recombinant OPN protein significantly (P < .05) increased MCP-1 mRNA and protein and induced its promoter activity. MCP-1 was found in 60% of invasive PDA lesions, of whom 66% were smokers. MCP-1 colocalized with OPN in PDA cells and in the malignant ducts, and correlated well with higher expression levels of OPN in the tissue from patients with invasive PDA.
CONCLUSION: Our data suggest that cigarette smoking and nicotine may contribute to PDA inflammation by inducing MCP-1 and provide a novel insight into a unique role for OPN in mediating these effects. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579680      PMCID: PMC2908036          DOI: 10.1016/j.surg.2010.05.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  27 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 2.  Monocyte chemoattractant protein-1.

Authors:  L Gu; S C Tseng; B J Rollins
Journal:  Chem Immunol       Date:  1999

Review 3.  Metabolism and disposition kinetics of nicotine.

Authors:  Janne Hukkanen; Peyton Jacob; Neal L Benowitz
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

4.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Authors:  T Ueno; M Toi; H Saji; M Muta; H Bando; K Kuroi; M Koike; H Inadera; K Matsushima
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

Review 5.  Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis.

Authors:  Xing Li Wang; Jian Wang
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 6.  Chronic pancreatitis and pancreatic cancer.

Authors:  Patrick Maisonneuve; Albert B Lowenfels
Journal:  Dig Dis       Date:  2002       Impact factor: 2.404

7.  Regulation of the macrophage content of neoplasms by chemoattractants.

Authors:  B Bottazzi; N Polentarutti; R Acero; A Balsari; D Boraschi; P Ghezzi; M Salmona; A Mantovani
Journal:  Science       Date:  1983-04-08       Impact factor: 47.728

8.  Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic beta-cells.

Authors:  Burak Kutlu; Martine I Darville; Alessandra K Cardozo; Décio L Eizirik
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

9.  The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

Authors:  Paolo Monti; Biagio Eugenio Leone; Federica Marchesi; Gianpaolo Balzano; Alessandro Zerbi; Francesca Scaltrini; Claudio Pasquali; Giliola Calori; Francesca Pessi; Cosimo Sperti; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

10.  Increased incidence of cancer in chronic pancreatitis.

Authors:  G Rocca; E Gaia; R Iuliano; M T Caselle; N Rocca; G Calcamuggi; G Emanuelli
Journal:  J Clin Gastroenterol       Date:  1987-04       Impact factor: 3.062

View more
  16 in total

1.  Nicotine induces pro-inflammatory response in aortic vascular smooth muscle cells through a NFκB/osteopontin amplification loop-dependent pathway.

Authors:  Yongyi Wang; Fei Zhang; Wengang Yang; Song Xue
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 2.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Authors:  Navneet Momi; Sukhwinder Kaur; Moorthy P Ponnusamy; Sushil Kumar; Uwe A Wittel; Surinder K Batra
Journal:  Carcinogenesis       Date:  2012-05-23       Impact factor: 4.944

3.  Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.

Authors:  Konrad Sarosiek; Elizabeth Jones; Galina Chipitsyna; Mazhar Al-Zoubi; Christopher Kang; Shivam Saxena; Ankit V Gandhi; Jocelyn Sendiky; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2015-01-13       Impact factor: 3.452

4.  Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.

Authors:  Anne E Sanders; William Maixner; Andrea G Nackley; Luda Diatchenko; Kunthel By; Vanessa E Miller; Gary D Slade
Journal:  J Pain       Date:  2011-10-26       Impact factor: 5.820

5.  Mechanisms for nicotine in the development and progression of gastrointestinal cancers.

Authors:  Kendal Jensen; Syeda Afroze; Md Kamruzzaman Munshi; Micheleine Guerrier; Shannon S Glaser
Journal:  Transl Gastrointest Cancer       Date:  2012-04

6.  Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.

Authors:  Anandi Sawant; Jonathan A Hensel; Diptiman Chanda; Brittney A Harris; Gene P Siegal; Akhil Maheshwari; Selvarangan Ponnazhagan
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

Review 7.  Effects of tobacco smoking and nicotine on cancer treatment.

Authors:  William P Petros; Islam R Younis; James N Ford; Scott A Weed
Journal:  Pharmacotherapy       Date:  2012-10       Impact factor: 4.705

8.  RAN GTPase and Osteopontin in Pancreatic Cancer.

Authors:  Shivam Saxena; Ankit Gandhi; Pei-Wen Lim; Daniel Relles; Konrad Sarosiek; Christopher Kang; Galina Chipitsyna; Jocelyn Sendecki; Charles J Yeo; Hwyda A Arafat
Journal:  Pancreat Disord Ther       Date:  2013-04-01

9.  Nicotinic acetylcholine receptor signaling in tumor growth and metastasis.

Authors:  Sandeep Singh; Smitha Pillai; Srikumar Chellappan
Journal:  J Oncol       Date:  2011-03-30       Impact factor: 4.375

10.  Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue.

Authors:  Junmin Song; Seiji Futagami; Hiroyuki Nagoya; Tetsuro Kawagoe; Hiroshi Yamawaki; Yasuhiro Kodaka; Atsushi Tatsuguchi; Katya Gudis; Taiga Wakabayashi; Masaoki Yonezawa; Mayumi Shimpuku; Yasuhiko Watarai; Katsuhiko Iwakiri; Yoshio Hoshihara; Hiroshi Makino; Masao Miyashita; Shinichi Tsuchiya; Yan Li; Sheila E Crowe; Choitsu Sakamoto
Journal:  J Clin Biochem Nutr       Date:  2013-03-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.